Atlas Trials

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Clinical trial NCT03650205 · UNKNOWN

Trial details

NCT number
NCT03650205
Sponsor
University of Sao Paulo
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
NeoplasmsHeart FailureCardiotoxicityChemotherapy EffectOncology
Start date
2019-01-22
Primary completion
2021-10-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.